ACHIEVE LIFE SCIENCES, INC.

Profile

Company Names

ACHIEVE LIFE SCIENCES, INC.
ONCOGENEX PHARMACEUTICALS, INC.

Addresses

1040 WEST GEORGIA, SUITE 1030, VANCOUVER, B.C., A1 V6E 4H1

1040 WEST GEORGIA, SUITE 1030, VANCOUVER, A1 V6E 4H1

1522 217TH PLACE S.E., BOTHELL, WA 98021

Phone Numbers

604-210-2217
4254879500

 

Entity Type:

CORPORATION

Industry:

BIOTECHNOLOGY, PHARMACEUTICALS

Year Incorporated:

> 5 years ago

State Incorporated:

DELAWARE

Total Amount Raised:

$28,900,000.00

Number of Funding Rounds:

2
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
2
2022-11-18 
$18,900,000.00 
$25,000,000.00 
$6,100,000.00 
 
1
2009-12-24 
$10,000,000.00 
$10,000,000.00 
$0.00 
Equity 
People
First Name
Middle Name
Last Name
Titles
Related Companies
STEPHEN 
 
ANDERSON 
EXECUTIVE OFFICER
ZUVACHEM INC   |  ONCOGENEX PHARMACEUTICALS, INC.   |  TRIPLE DOT REPRISE, INC.   |  SHAPE MEDICAL SYSTEMS, INC.   |  PREFERRED INCOME FUNDS, LLC   |  WA OPPORTUNITY 2 LLC   |  MACROTOPE, INC.   |  WA OPPORTUNITY 5 LLC
JOHN 
 
BENCICH 
EXECUTIVE OFFICER, DIRECTOR
ALLOZYNE INC   |  INTEGRATED DIAGNOSTICS, INC.   |  ACHIEVE LIFE SCIENCES, INC.
MICHELLE 
 
BURRIS 
DIRECTOR
TRUBION PHARMACEUTICALS, INC   |  ONCOGENEX PHARMACEUTICALS, INC.
ANTHONY 
 
CLARKE 
EXECUTIVE OFFICER
10321 BURNET LP   |  ACHIEVE LIFE SCIENCES, INC.   |  NRG SMALL BALANCE LP   |  4205 SPEEDWAY LP   |  NRG SOUTH POINT LP
NEIL 
JAMES 
CLENDENINN 
DIRECTOR
ONCOGENEX PHARMACEUTICALS, INC.
SCOTT 
 
CORMACK 
DIRECTOR, EXECUTIVE OFFICER
ONCOGENEX PHARMACEUTICALS, INC.
VAUGHN 
 
HIMES 
DIRECTOR
ACHIEVE LIFE SCIENCES, INC.
CINDY 
 
JACOBS 
EXECUTIVE OFFICER, DIRECTOR
ONCOGENEX PHARMACEUTICALS, INC.   |  PACYLEX PHARMACEUTICALS INC.   |  ACHIEVE LIFE SCIENCES, INC.
DONALD 
 
JOSEPH 
DIRECTOR
HIGHWAY TO HEALTH, INC.   |  SORBENT THERAPEUTICS INC   |  ACHIEVE LIFE SCIENCES, INC.
BRIDGET 
 
MARTELL 
DIRECTOR
ACHIEVE LIFE SCIENCES, INC.   |  AYALA PHARMACEUTICALS, INC.   |  ALIGOS THERAPEUTICS, INC.
MICHAEL 
A. 
MARTINO 
DIRECTOR
ONCOGENEX PHARMACEUTICALS, INC.   |  AMBIT BIOSCIENCES CORP
MARTIN 
 
MATTINGLY 
DIRECTOR
TRACON PHARMACEUTICALS, INC.   |  ACHIEVE LIFE SCIENCES, INC.
JAY 
 
MOYES 
DIRECTOR
INTEGRATED DIAGNOSTICS, INC.   |  SERA PROGNOSTICS, INC.   |  ACHIEVE LIFE SCIENCES, INC.
RICHARD 
 
STEWART 
DIRECTOR
LATTICE INC   |  ACHIEVE LIFE SCIENCES, INC.   |  MOORE SPECIALTY CREDIT FUND III (OFFSHORE), LP   |  MOORE SPECIALTY CREDIT FUND III, LP
DWIGHT 
 
WINSTEAD 
DIRECTOR
ONCOGENEX PHARMACEUTICALS, INC.
JAIME 
 
XINOS 
EXECUTIVE OFFICER
ACHIEVE LIFE SCIENCES, INC.
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2022-12-08
D/A
Link
BIOTECHNOLOGY 
IN VITRO + IN VIVO DIAGNOSTIC SUBSTANCES [2835] 
DECLINE TO DISCLOSE 
 
2022-11-18 
2022-11-29
D
Link
BIOTECHNOLOGY 
IN VITRO + IN VIVO DIAGNOSTIC SUBSTANCES [2835] 
DECLINE TO DISCLOSE 
 
2022-11-18 
2010-01-04
D
Link
PHARMACEUTICALS 
IN VITRO + IN VIVO DIAGNOSTIC SUBSTANCES [2835] 
NO REVENUES 
Equity 
2009-12-24 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#